Targeting TLR2 Attenuates Pulmonary Inflammation and Fibrosis by Reversion of Suppressive Immune Microenvironment
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Pulmonary fibrosis is a consequence of chronic lung injury and is associated with a high mortality. Despite the pathogenesis of pulmonary fibrosis remaining as an enigma, immune responses play a critical role in the deregulation of wound healing process after lung injury, which leads to fibrosis. Accumulating evidence argues the rationales for current treatments of pulmonary fibrosis using immunosuppressive agents such as corticosteroids. In this study, we report that bleomycin (BLM), a well-known fibrogenic agent functioning as a TLR2 agonist, induced the maturation of dendritic cells and release of cytokines. The BLM activation of TLR2 mediated a time-dependent alteration of immune responses in the lung. These responses resulted in an increase in the tissue-infiltrating proinflammatory cells and cytokines in the early period initially following BLM exposure and an increase in the tissue-infiltrating suppressive immune cells and factors during the later period following BLM exposure. TLR2 deficiency, however, reduced pulmonary inflammation, injury, and subsequently attenuated pulmonary fibrosis. Targeting TLR2 by a TLR2-neutralizing Ab not only markedly decreased animal death but also protected animals from the development of pulmonary fibrosis and reversed the established pulmonary fibrosis through regulating BLM-induced immunosuppressive microenvironments. Our studies suggest that TLR2 is a promising target for the development of therapeutic agents against pulmonary fibrosis and that eliminating immunosuppressive cells and factors via immunostimulants is a novel strategy for fibro-proliferative diseases. Moreover, combining BLM with an anti-TLR2 Ab or TLR2 antagonist for cancer therapy will improve the BLM therapeutic profile by enhancing anti-cancer efficacy and reducing systemic inflammation and pulmonary fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257
Transforming growth factor-β in T-cell biology
Gorelik, L., & Flavell, R. A. (2002) · Nature Reviews Immunology · doi:10.1038/nri704 · Cited by 792 · cited 1×
“TGF- 1 is the most powerful physiological immunosuppressor in mammals (38), and the TGF- 1/Smad3 pathway is critical for damaged tissue to switch from a Th1- to Th2- predominated response.”
BackgroundWelte, T., Zhang, S. S. M., Wang, T., Zhang, Z., Hesslein, D. G. T., Yin, Z., Kano, A., Iwamoto, Y., Li, E., Craft, J. E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237137100 · Cited by 381 · cited 1×
“Although prior studies suggest that Stat3 has a largely anti-inflammatory role in innate immune responses, elucidation of the role of Stat3 in biologic responses in general has been hindered by the fact that deletion of the Stat3 gene results in embryonic lethality (40).”
BackgroundLoss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
Ogata, H., Chinen, T., Yoshida, T., Kinjyo, I., Takaesu, G., Shiraishi, H., Iida, M., Kobayashi, T., & Yoshimura, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209281 · Cited by 246 · cited 1×
“(41) found that TGF- 1 is a target gene of Stat3 and that Stat3 enhances hepatic fibrosis through the up-regulation of TGF-â1 expression.”
BackgroundRole of Repeated Lung Injury and Genetic Background in Bleomycin-Induced Fibrosis
Chung, M. P., Monick, M. M., Hamzeh, N. Y., Butler, N. S., Powers, L. S., & Hunninghake, G. W. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0029oc · Cited by 135
Cited by
Mi, S., Li, Z., Yang, H.-Z., Liu, H., Wang, J.-P., Ma, Y.-G., Wang, X.-X., Liu, H.-Z., Sun, W., & Hu, Z.-W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004081 · Cited by 370
“Although a number of studies have highlighted the differential regulatory roles for Th1 and Th2 responses in the pathogenesis of tissue fibrosis (15, 31), it is unclear how the Th1/2 balance affects the progression of tissue fibrosis.”
BackgroundMethodInfluentialSelf-citationYang, H.-Z., Wang, J.-P., Mi, S., Liu, H.-Z., Cui, B., Yan, H.-M., Yan, J., Li, Z., Liu, H., Hua, F., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.09.019 · Cited by 155
Self-citationInterleukin-17A antagonist attenuates radiation-induced lung injuries in mice
Wang, B.-Z., Wang, L.-P., Han, H., Cao, F.-L., Li, G.-Y., Xu, J.-L., Wang, X.-W., & Wang, L.-X. (2014) · Experimental Lung Research · doi:10.3109/01902148.2013.872210 · Cited by 33
“Collagen deposition was evaluated by detecting the total hydroxyproline content of the lungs according to the revised Reddy GK method [26, 27].”
MethodHuang, Q., Chu, S., Yin, X., Yu, X., Kang, C., Li, X., & Qiu, Y. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.240.269 · Cited by 29
Metadata
- Authors
- Yang, H.-Z., Cui, B., Liu, H.-Z., Chen, Z.-R., Yan, H.-M., Hua, F., & Hu, Z.-W.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01-01
- Volume
- 182
- Issue
- 1
- Pages
- 692-702
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1716654662
- Cited by
- 103
- References
- 6
- FWCI
- 7.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting TLR2 Attenuates Pulmonary Inflammation and Fibrosis by Reversion of Suppressive Immune Microenvironment. https://app.cochat.ai/papers/10.4049/jimmunol.182.1.692
- The paper
- Yang, H.-Z., Cui, B., Liu, H.-Z., Chen, Z.-R., Yan, H.-M., Hua, F., & Hu, Z.-W. (2009). Targeting TLR2 Attenuates Pulmonary Inflammation and Fibrosis by Reversion of Suppressive Immune Microenvironment. The Journal of Immunology. https://doi.org/10.4049/jimmunol.182.1.692
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.